Search Results - Toru Haneda

Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage by Yuji Yamamoto, Junji Matsui, Tomohiro Matsushima, Hiroshi Obaishi, Kazuki Miyazaki, Katsuji Nakamura, Osamu Tohyama, Taro Semba, Atsumi Yamaguchi, Sachi Hoshi, Fusayo Mimura, Toru Haneda, Yoshio Fukuda, Junichi Kamata, Keiko Takahashi, Masayuki Matsukura, Toshiaki WAKABAYASHI, Makoto Asada, K. Nomoto, Tatsuo Watanabe, Zoltán Dezső, Kentaro Yoshimatsu, Yasuhiro Funahashi, Akihiko Tsuruoka